A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer. (Q33370110)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer. |
scientific article |
Statements
A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer (English)
G D'Agostino
J del Campo
B Mellado
M A Izquierdo
T Minarik
L Cirri
L Marini
1 January 2006